Filtered By:
Specialty: Universities & Medical Training
Source: Journal of Zhejiang University. Science. B.
Condition: Thrombosis
This page shows you your search results in order of relevance.
Order by Relevance | Date
Total 1 results found since Jan 2013.
Metabolic benefits of rivaroxaban in non-valvular atrial fibrillation patients after radiofrequency catheter ablation
ConclusionsPatients with NVAF receiving rivaroxaban after RFCA procedures appear to benefit from a metabolic perspective compared with warfarin, providing practical clinical reference for the choice of the anticoagulant. Rivaroxaban seems to be as safe and effective in preventing thromboembolic events as warfarin for these patients.
Source: Journal of Zhejiang University. Science. B. - November 1, 2017 Category: Universities & Medical Training Source Type: research
